Cardio Diagnostics announces 1-for-30 reverse stock split to regain Nasdaq compliance

Cardio Diagnostics Holdings, Inc.

Reverse split at 1:30, effective after close May 12; trading begins May 13 under CDIO.
Outstanding shares reduced from ~52M to ~1.7M; authorized shares remain 300M.
New CUSIP 14159C202; fractional shares rounded up/down by DTC.
Split approved by shareholders Nov 15, 2024; Board set ratio on April 10, 2025.
Split adjusts warrants, options, and equity plan shares proportionately.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Cardio Diagnostics Holdings, Inc.: Certificate of Amendment to effect a 1-for-30 reverse stock split, filed with Delaware Secretary of State effective after market close on May 12, 2025 (effective 2025-05-12).

Change: charter amendment
Effective: 2025-05-12

Exact text from the filing

On May 12, 2025, the Company filed the Certificate of Amendment with the Delaware Secretary of State to effect the Reverse Stock Split, effective immediately after the close of trading on Nasdaq on May 12, 2025 (the "Effective Time").

View on SEC.gov

Browse all governance changes →

Cardio Diagnostics Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001079973-25-000781

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.